TGA Approval

SAPHNELO anifrolumab 300 mg concentrated injection vial (350930)

ARTG ID

350930

ARTG Name

SAPHNELO anifrolumab 300 mg concentrated injection vial

Sponsor

AstraZeneca Pty Ltd

ARTG Date

March 29, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ASTRAZENECA PTY LTD

https://medical-cdn.nocode.com/drug_tga/b8365f93468eea27b7e59416160a7ba7.pdf

https://medical-cdn.nocode.com/drug_tga/d375ad23d1520a3068d460a2ff8752bd.pdf

Ingredient Name

anifrolumab

Empowering clinical research with data-driven insights and AI-powered tools.

SAPHNELO anifrolumab 300 mg concentrated injection vial (350930) - TGA 批准文号 | MedPath